Last $14.23 USD
Change Today -0.24 / -1.66%
Volume 97.9K
As of 8:10 PM 11/21/14 All times are local (Market data is delayed by at least 15 minutes).

tandem diabetes care inc (TNDM) Snapshot

Open
$14.50
Previous Close
$14.47
Day High
$15.43
Day Low
$14.17
52 Week High
01/14/14 - $30.25
52 Week Low
07/31/14 - $12.36
Market Cap
334.4M
Average Volume 10 Days
89.2K
EPS TTM
$-4.78
Shares Outstanding
23.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for TANDEM DIABETES CARE INC (TNDM)

tandem diabetes care inc (TNDM) Related Businessweek News

No Related Businessweek News Found

tandem diabetes care inc (TNDM) Details

Tandem Diabetes Care, Inc., a medical device company, focuses on the design, development, and commercialization of various products for people with insulin-dependent diabetes in the United States. The company’s products include t:slim Insulin Delivery System that comprises t:slim pump, its disposable cartridge, and an infusion set; and t:connect Diabetes Management Application, a PC and Mac-compatible, cloud-based data management application that provides a visual way to display therapy management data from the pump and supported blood glucose meters for users, their caregivers, and their healthcare providers. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was founded in 2006 and is headquartered in San Diego, California.

324 Employees
Last Reported Date: 03/6/14
Founded in 2006

tandem diabetes care inc (TNDM) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $472.1K
Chief Financial Officer and Principal Account...
Total Annual Compensation: $362.6K
Chief Commercial Officer and Executive Vice P...
Total Annual Compensation: $265.0K
Chief Administrative Officer
Total Annual Compensation: $275.2K
Compensation as of Fiscal Year 2013.

tandem diabetes care inc (TNDM) Key Developments

Tandem Diabetes Care, Inc. Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014; Provides Earnings Guidance for the Year Ending December 31, 2014

Tandem Diabetes Care, Inc. reported unaudited earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported sales of USD 13.514 million compared to USD 7.776 million a year ago. Operating loss was USD 19.006 million compared to USD 12.128 million a year ago. Net loss was USD 19.899 million compared to USD 13.061 million a year ago. Basic and diluted loss per share was USD 0.85 compared to USD 60.96 a year ago. For the nine months, the company reported sales of USD 31.834 million compared to USD 18.762 million a year ago. Operating loss was USD 58.161 million compared to USD 32.971 million a year ago. Net loss was USD 61.058 million compared to USD 39.525 million a year ago. Basic and diluted loss per share was USD 2.64 compared to USD 187.33 a year ago. For the year ending December 31, 2014, the company provided earnings guidance. Sales are estimated to be in the range of USD 48.0 million to USD 50.0 million, and operating margin is estimated to be in the range of negative 150% to 160%, which includes approximately USD 15.0 million to USD 16.0 million in non-cash, stock-based compensation expense.

Tandem Diabetes Care, Inc. to Report Q3, 2014 Results on Nov 06, 2014

Tandem Diabetes Care, Inc. announced that they will report Q3, 2014 results After-Market on Nov 06, 2014

Tandem Diabetes Care, Inc., Q3 2014 Earnings Call, Nov 06, 2014

Tandem Diabetes Care, Inc., Q3 2014 Earnings Call, Nov 06, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TNDM:US $14.23 USD -0.24

TNDM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Becton Dickinson and Co $130.38 USD -0.02
DexCom Inc $50.37 USD -0.48
Insulet Corp $45.26 USD -0.20
Medtronic Inc $72.49 USD +0.41
Smiths Group PLC 1,192 GBp +9.00
View Industry Companies
 

Industry Analysis

TNDM

Industry Average

Valuation TNDM Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 7.9x
Price/Book 5.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 5.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TANDEM DIABETES CARE INC, please visit www.tandemdiabetes.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.